Company Summary

Vivodyne is changing how scientists study human biology & develop therapeutics. Their platform technology creates a new preclinical drug development pipeline – Pipeline V – that starts and ends in lab-grown human tissues. The company was founded at the University of Pennsylvania by Bioengineering PhD Andrei Georgescu and Associate Professor of Bioengineering Dan Huh.

Year Founded:  2021

Key Executives:
• Andrei Georgescu, Co-Founder & CEO
• Dan Huh, PhD, Co-Founder & CSO

Location:  Philadelphia, PA


Company Status:  Private

Year Invested:  2021

Investment Status:  Current

Board Member:
Alex Andrianopoulos